Sakinah Shaw
Psychiatric/Mental Health · Hot Springs, ARNPI 1437856820
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.9%), speaking fees and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by AbbVie at 54.0% of the total. 2025 is the largest year on record at $5,414, 7.6 times the $713 reported in 2023. Among psychiatric/mental health clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $32.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Supernus Pharmaceuticals, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$447
- Teva Pharmaceuticals USA, Inc.$383
- E.r. Squibb & Sons, L.L.C.$110
- plus $418 from 8 others
What the payments were for
- Speaking & faculty fees$3,00039%
- Travel & lodging$1492%
- Food & beverage$4,26956%
- Education$2233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $4,126 |
| Supernus Pharmaceuticals, Inc. | 76 | $1,116 |
| Otsuka America Pharmaceutical, Inc. | 50 | $1,041 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $447 |
| Teva Pharmaceuticals USA, Inc. | 10 | $383 |
| E.r. Squibb & Sons, L.L.C. | 5 | $110 |
| Lundbeck LLC | 5 | $101 |
| Alkermes, Inc. | 4 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Indivior Inc. | 2 | $48 |
| Johnson & Johnson | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Braeburn Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$3,383
- REXULTI$211
- QELBREE$126
- CAPLYTA$115
- ABILIFY ASIMTUFII$104
- ABILIFY MAINTENA$104
How this compares
$7,641 in reported general payments places this provider in the 95th percentile of 359 psychiatric/mental health providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 31 | $44,218 |
| RexultiBrexpiprazole | 24 | $37,660 |
| Aripiprazole | 48 | $2,502 |
| Lurasidone Hcl | 11 | $1,160 |
| Atomoxetine Hcl | 12 | $871 |
| Buspirone Hcl | 59 | $724 |
| Oxcarbazepine | 19 | $675 |
| Fluoxetine Hcl | 64 | $518 |
| Prazosin Hcl | 37 | $444 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 34 | $436 |
| Quetiapine Fumarate | 34 | $329 |
| Bupropion XlBupropion Hcl | 20 | $319 |
| Olanzapine | 27 | $310 |
| Benztropine Mesylate | 30 | $297 |
| Duloxetine Hcl | 24 | $272 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $4,126 | $44,21831 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,041 | $37,66024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 359 psychiatric/mental health providers in Arkansas.
Other psychiatric/mental health in Hot Springs
- Charl BuxtonHot Springs$3K
- Stephanie BohannonFayetteville$32K
- Michael BelinSherwood$30K
- Sarah RamseySearcy$12K
- Mallori LevengoodPine Bluff$11K
- Jennifer PenneFayetteville$11K
- Stephanie ParishSearcy$9K
- Elizabeth HardyTexarkana$8K
- Tammy HawkinsJonesboro$8K
- Cara MeckfesselLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.